| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_63a392fbbb2d925c6e169d1144d754a2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-902 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3015
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-574 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 |
| filingDate |
2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c16d2e3ab13081acdbfb45efc08848d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb6d498df8dda1c94fb3c21385aacd25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_563ad0d5b6f485bf7c38f96c136ffc46
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6aeb2109b211054b74f041358df75a68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f69d6305e4b5b9ba7e5fd6d683bdf18f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_da626004b433cdc73f28b7e9dac19e48 |
| publicationDate |
2021-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2747929-C2 |
| titleOfInvention |
Monoclonal antibody that specifically binds to thioredoxin-1 and its use |
| abstract |
FIELD: biochemistry.SUBSTANCE: invention relates to the field of biochemistry, in particular to a monoclonal antibody that specifically binds to Thioredoxin-1. Also disclosed is a set containing the specified antibody; a nucleic acid molecule encoding the specified antibody; a recombinant vector containing the specified nucleic acid molecule; a host cell containing the specified vector. Methods of obtaining information required for the diagnosis of breast cancer associated with Thioredoxin-1 are disclosed.EFFECT: invention has ability to effectively treat diseases associated with Thioredoxin-1.31 cl, 9 dwg, 13ex, 12 tbl |
| priorityDate |
2016-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |